Burjeel Holdings delivers record FY22 results with net profit up 52% to AED 355mln

Burjeel Holdings delivers record FY22 results with net profit up 52% to AED 355mln

- Revenue of AED 3.92 billion up 17% y-o-y with EBITDA of AED 878 million up 13%

- Strong financial position with Net Debt/EBITDA* at 1.5x at the end of the period

- Delivering on our strategy to grow patient yields and drive utilization across our network

- Entry into Saudi Arabia underway through joint venture with Leejam Sports

- Expected to deliver robust growth in 2023 with group revenue expected to grow organically in the high-teens and EBITDA margins to improve to at least 2021 levels

- Various strategic growth opportunities, including M&A, under consideration

Abu Dhabi, United Arab Emirates: Burjeel Holdings PJSC (“Burjeel” or “the Group”), a leading Healthcare Services Provider in the UAE and MENA listed on the Abu Dhabi Securities Exchange (“ADX”) (SYMBOL: BURJEEL; ISIN: AEE01119B224), today announced its preliminary financial results for the twelve-month and three-month period ended 31 December 2022.

- Net Profit of AED 355 million up 52% from the prior year, demonstrating the Group’s ability to deliver on its yield enhancement strategy

- Revenue of AED 3.92 billion, up 17% YoY, driven by 125% growth at our flagship hospital Burjeel Medical City (BMC)

- EBITDA of AED 878 million, up 13% YoY, with EBITDA margin stable at 22%. Benefitted from strong